Foreign-Source Bulk Ibuprofen Impurity Review Urged By Suppliers
This article was originally published in The Tan Sheet
Executive Summary
Incremental consumer exposure to lead or chromium impurities in bulk ibuprofen produced off-shore should be addressed by FDA as it develops a final rule to include the ingredient in the internal analgesics monograph, ingredient suppliers recommend in comments to the agency